V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001210 | 230010516 | null | 85.7 | Curative (C) | 2018-02-14 | 2018-03-01 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 101643330 |
| 230001216 | 230010517 | null | null | null | null | 2021-03-07 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101143165 |
| 230001231 | 230010518 | null | null | null | null | 2020-07-11 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100570423 |
| 230001232 | 230010519 | 1.65 | 67.3 | Adjuvant (A) | null | 2018-09-21 | null | 2 | N | CARBOPLATIN + PACLITAXEL | 100569547 |
| 230001234 | 230010520 | 1.66 | 74.7 | Adjuvant (A) | null | 2020-11-05 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100186729 |
| 230001235 | 230010521 | null | null | null | 2021-07-21 | 2021-07-22 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101312298 |
| 230001247 | 230010526 | null | null | null | null | 2020-03-18 | CARBOPLATIN + PACLITAXEL | null | null | CARBOPLATIN + PACLITAXEL | 100863642 |
| 230001271 | 230010530 | null | null | null | null | 2020-03-22 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100012011 |
| 230001272 | 230010531 | 1.64 | null | null | 2018-06-08 | 2018-07-10 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100176110 |
| 230001275 | 230010532 | null | null | null | null | 2018-08-31 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100824173 |
| 230001276 | 230010533 | null | null | null | null | 2018-12-19 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100113407 |
| 230001285 | 230010534 | 1.63 | null | null | 2019-02-02 | 2019-02-14 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 101742436 |
| 230001307 | 230010538 | 1.56 | null | null | null | 2020-05-31 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100027980 |
| 230001329 | 230010541 | 1.64 | 71 | Curative (C) | null | 2020-11-06 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100257922 |
| 230001336 | 230010543 | null | null | null | null | 2020-04-06 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100167056 |
| 230001339 | 230010544 | 1.62 | 100 | null | 2020-07-05 | 2020-07-26 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 101049833 |
| 230001341 | 230010545 | 1.66 | 73 | Adjuvant (A) | null | 2019-08-16 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100129127 |
| 230001344 | 230010546 | 1.61 | 77.2 | null | 2021-02-01 | 2021-02-15 | null | 02 | null | CARBOPLATIN + PACLITAXEL | 100946609 |
| 230001351 | 230010548 | null | null | null | null | 2019-12-29 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101745558 |
| 230001353 | 230010549 | 1.62 | 66.6 | Neo-adjuvant (N) | 2018-11-22 | 2018-11-24 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101246172 |
| 230001359 | 230010552 | 1.61 | null | null | 2017-01-31 | 2017-02-07 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101843493 |
| 230001381 | 230010556 | null | 75.3 | null | 2022-03-08 | 2022-03-23 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101298975 |
| 230001382 | 230010557 | null | null | null | null | 2021-04-15 | null | null | null | PEMBROLIZUMAB | 101834209 |
| 230001397 | 230010559 | 1.5 | 83.3 | null | 2019-03-17 | 2019-04-07 | Trial Unspecified | 02 | null | PEMBROLIZUMAB | 100176716 |
| 230001399 | 230010560 | null | null | Adjuvant (A) | 2022-04-11 | 2022-04-24 | null | N | N | CARBOPLATIN | 100703251 |
| 230001407 | 230010562 | 1.7 | 61.7 | null | null | 2017-08-11 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100726201 |
| 230001409 | 230010563 | 1.67 | 53.2 | Neo-adjuvant (N) | 2019-09-03 | 2019-10-16 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101802730 |
| 230001423 | 230010565 | 1.65 | 73.6 | null | null | 2022-05-03 | null | null | null | OLAPARIB | 101468533 |
| 230001443 | 230010571 | 1.57 | 90 | Palliative (P) | 2020-12-15 | 2020-12-26 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100244625 |
| 230001452 | 230010573 | 1.68 | 63.5 | null | null | 2021-11-08 | CARBOPLATIN + GEMCITABINE | N | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100356661 |
| 230001460 | 230010575 | 1.58 | 60 | null | null | 2019-09-09 | null | 2 | null | CAPECITABINE + OXALIPLATIN | 100042227 |
| 230001467 | 230010576 | 1.67 | 77.4 | Palliative (P) | 2021-03-16 | 2021-03-16 | null | null | null | NIVOLUMAB | 101163575 |
| 230001474 | 230010577 | null | null | null | 2022-03-14 | 2022-03-14 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100297309 |
| 230001486 | 230010578 | null | null | null | null | 2021-12-04 | null | null | null | HYDROXYCARBAMIDE | 101185325 |
| 230001499 | 230010579 | 1.49 | 73.3 | Palliative (P) | 2017-11-10 | 2018-01-24 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100260155 |
| 230001500 | 230010580 | 1.66 | 52 | null | 2021-11-03 | 2021-11-07 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100491722 |
| 230001504 | 230010582 | null | null | null | 2018-12-29 | 2019-01-05 | null | N | null | NIRAPARIB | 100267050 |
| 230001508 | 230010583 | null | null | null | 2016-12-25 | 2017-05-11 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100056398 |
| 230001540 | 230010590 | 1.65 | 75 | Palliative (P) | 2018-07-22 | 2018-07-30 | null | null | Y | CISPLATIN + CYCLOPHOSPHAMIDE + DOXORUBICIN | 100852176 |
| 230001549 | 230010591 | 1.48 | 50.4 | null | 2020-02-03 | 2020-02-17 | null | null | null | BEVACIZUMAB | 100038890 |
| 230001555 | 230010592 | 1.97 | 87.05 | null | null | 2022-04-30 | Cyclophosphamide oral | 02 | null | IPILIMUMAB + NIVOLUMAB | 101745389 |
| 230001565 | 230010594 | null | null | null | null | 2019-07-29 | null | 99 | null | OLAPARIB | 101673037 |
| 230001567 | 230010595 | null | null | null | 2022-03-24 | 2022-04-03 | Niraparib | 02 | null | NIRAPARIB | 101215167 |
| 230001568 | 230010596 | 1.66 | 85.9 | null | null | 2018-11-20 | null | null | null | OLAPARIB | 100179612 |
| 230001571 | 230010597 | 1.78 | 94 | null | 2022-04-07 | 2022-04-16 | Olaparib | 02 | null | OLAPARIB | 100538691 |
| 230001581 | 230010598 | 1.57 | 73.6 | Palliative (P) | 2022-03-21 | 2022-04-25 | null | null | N | IPILIMUMAB + NIVOLUMAB | 100520668 |
| 230001583 | 230010599 | 1.62 | 64.7 | null | 2020-06-19 | 2020-06-19 | ICON8B TRIAL | 02 | null | CISPLATIN + GEMCITABINE | 100144511 |
| 230001588 | 230010600 | 1.71 | 101 | null | null | 2020-02-24 | Olaparib | 02 | null | OLAPARIB | 100263283 |
| 230001589 | 230010601 | 1.57 | 53.9 | null | 2018-04-25 | 2018-10-31 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100729650 |
| 230001597 | 230010603 | 1.62 | 61.5 | null | 2020-03-17 | 2020-03-17 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101314662 |